Equillium, Inc. (EQ)
NASDAQ: EQ · IEX Real-Time Price · USD
0.818
+0.018 (2.21%)
At close: Jul 26, 2024, 4:00 PM
0.820
+0.002 (0.23%)
After-hours: Jul 26, 2024, 6:28 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $28.83 million as of July 26, 2024. Its market cap has decreased by -3.91% in one year.
Market Cap
28.83M
Enterprise Value
-2.74M
1-Year Change
-3.91%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $233.80M to $28.83M, a decrease of -87.67%. That is a compound annual growth rate of -30.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 28.20M | 11.02% |
| Dec 29, 2023 | 25.40M | -30.22% |
| Dec 30, 2022 | 36.40M | -67.15% |
| Dec 31, 2021 | 110.80M | -16.25% |
| Dec 31, 2020 | 132.30M | 125.38% |
| Dec 31, 2019 | 58.70M | -58.60% |
| Dec 31, 2018 | 141.80M | -39.35% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 28.47M |
| ProMIS Neurosciences | 28.44M |
| Bolt Biotherapeutics | 28.25M |
| Holdco Nuvo Group D.G | 28.13M |
| Orgenesis | 28.09M |
| Palatin Technologies | 27.75M |
| Accelerate Diagnostics | 27.61M |
| ATI Physical Therapy | 27.56M |